Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study

BACKGROUND: COVID-19 causes acute respiratory distress syndrome (ARDS) and depletes the lungs of surfactant, leading to prolonged mechanical ventilation and death. The feasibility and safety of surfactant delivery in COVID-19 ARDS patients have not been established. METHODS: We performed retrospecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Piva, Simone, DiBlasi, Robert M., Slee, April E., Jobe, Alan H., Roccaro, Aldo M., Filippini, Matteo, Latronico, Nicola, Bertoni, Michele, Marshall, John C., Portman, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812332/
https://www.ncbi.nlm.nih.gov/pubmed/33461535
http://dx.doi.org/10.1186/s12931-020-01603-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812332/
https://www.ncbi.nlm.nih.gov/pubmed/33461535
http://dx.doi.org/10.1186/s12931-020-01603-w

Ejemplares similares